Physician profile
Vernon T Mackey
NPI 1821046772
$3,516.95
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $690 · 2020: $351 · 2021: $592 · 2022: $856 · 2023: $519 · 2024: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879 · Education: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $879.19 |
| Education | $148.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,435.86 | 2019-2024 | |
| Janssen Biotech, INC. | $843.24 | 2019-2024 | Tremfya, Simponi Aria, Simponi |
| Novartis Pharmaceuticals Corporation | $186.79 | 2019-2023 | |
| Genzyme Corporation | $151.22 | 2019-2024 | |
| Ucb, INC. | $146.86 | 2019-2024 | Bimzelx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $136.62 | 2019-2020 | |
| Lilly USA, LLC | $104.99 | 2019-2024 | Olumiant |
| Arcutis Biotherapeutics, INC. | $87.68 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.61 | 2022-2024 | Cyltezo, Spevigo |
| Sun Pharmaceutical Industries INC. | $73.30 | 2021-2024 | |
| Pfizer INC. | $55.55 | 2019-2022 | |
| Dermira, INC. | $33.52 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $31.67 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $29.43 | 2021 | |
| Organon LLC | $28.53 | 2023 | Hadlima |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $25.00 | 2022 | |
| Leo Pharma INC. | $24.98 | 2021 | |
| Amgen INC. | $22.41 | 2020 | |
| Mylan Institutional INC. | $14.69 | 2023 | Hulio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vernon Mackey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.